ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 996,64
0,49%
Dow Jones
38 852,27
0,46%
DAX
18 175,21
1,01%
Brent Oil
83,475
0,42%
Bitcoin
63 343,87
-1,02%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Unicycive Therapeutics Inc (UNCY)

  7. Unicycive Therapeutics Inc (UNCY) Actualités

UNCY Unicycive Therapeutics Inc

1,19
0,07 (6,25%)
Après les heures de négociation
Dernière mise à jour : 00:16:29
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Unicycive Therapeutics Inc UNCY NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,07 6,25% 1,19 00:16:29
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,13 1,10 1,21 1,18 1,12
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
10/4/202413:03GLOBEUnicycive Therapeutics to Present at the Noble Capital..
28/3/202421:15GLOBEUnicycive Therapeutics Announces Full Year 2023 Financial..
25/3/202412:03GLOBEUnicycive Therapeutics to be Featured in Multiple..
14/3/202412:03GLOBEUnicycive Announces $50 Million Private Placement
13/3/202412:03GLOBEUnicycive Therapeutics Delivers Both an Oral and Poster..
07/3/202422:12GLOBEUnicycive Therapeutics Completes Enrollment in Pivotal..
04/3/202413:03GLOBEUnicycive Therapeutics Announces Orphan Drug Designation..
21/2/202422:06EDGAR2Form 8-K - Current report
14/2/202413:03GLOBEUnicycive Therapeutics to Present Two Posters on..
29/1/202413:03GLOBEUnicycive Therapeutics Announces Both an Oral and Poster..
23/1/202413:03GLOBEUnicycive Therapeutics Issues Shareholder Letter to..
22/1/202422:27EDGAR2Form SC 13G - Statement of acquisition of beneficial..
18/12/202313:03GLOBEUnicycive Therapeutics Announces Enrollment of First Patient..
08/12/202322:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/11/202313:03GLOBEUnicycive Therapeutics to Participate in Two Investor..
14/11/202322:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202322:15GLOBEUnicycive Announces Third Quarter 2023 Financial Results and..
23/10/202317:12EDGAR2Form 8-K - Current report
23/10/202313:03GLOBEUnicycive Therapeutics Reaches Alignment with the FDA on..
25/9/202322:05EDGAR2Form 8-K - Current report
07/9/202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202322:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/9/202315:16EDGAR2Form 8-K - Current report
06/9/202313:03GLOBEUnicycive Therapeutics Strengthens Board of Directors with..
31/8/202322:16EDGAR2Form 8-K - Current report
30/8/202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202313:03GLOBEUnicycive Therapeutics Featured on Nasdaq Amplify Issuer..
14/8/202323:36GLOBEUnicycive Announces Second Quarter 2023 Financial Results..
14/8/202323:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202322:15EDGAR2Form 8-K - Current report
26/7/202312:05EDGAR2Form 8-K - Current report
20/7/202313:03GLOBEUnicycive Therapeutics to Participate in the H.C. Wainwright..
18/7/202313:03GLOBEUnicycive Therapeutics Announces Publication of Positive..
14/7/202322:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/7/202301:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/7/202301:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/7/202300:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202323:04GLOBEUnicycive Therapeutics Provides Regulatory Update on..
16/6/202313:38GLOBEUnicycive to Participate in the Healthcare Virtual..
16/5/202314:29GLOBEUnicycive Announces First Quarter 2023 Financial Results and..

Dernières Valeurs Consultées

NASDAQ
UNCY
Unicycive Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés